NCT06876857

Brief Summary

Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50,000

participants targeted

Target at P75+ for all trials

Timeline
594mo left

Started Feb 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Feb 2025Feb 2075

Study Start

First participant enrolled

February 25, 2025

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 10, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 14, 2025

Completed
50 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2075

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2075

Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

50 years

First QC Date

March 10, 2025

Last Update Submit

March 10, 2025

Conditions

Keywords

donatebiobankbrainbiospecimenAlzheimer's DiseaseAutismHuntington's Disease

Outcome Measures

Primary Outcomes (1)

  • Receipt of donated brain tissue and biospecimens for research and educational purposes

    The UCF CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma.

    75 years

Study Arms (1)

Donated brain tissue and biospecimens

Persons with brain disease and/ or brain trauma to be used to support research studies aimed at improving the diagnosis and treatment of brain diseases.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will donate brain tissue for research and education, aimed at improving the diagnosis and treatment of brain diseases.

You may qualify if:

  • Be 18 years or older.
  • Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent.

You may not qualify if:

  • minors (under age 18).
  • prisoners.
  • pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Central Florida

Orlando, Florida, 32827, United States

RECRUITING

MeSH Terms

Conditions

Brain InjuriesBrain DiseasesAlzheimer DiseaseAutistic DisorderHuntington Disease

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesDementiaTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersBasal Ganglia DiseasesChoreaDyskinesiasMovement DisordersHeredodegenerative Disorders, Nervous SystemGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCognition Disorders

Central Study Contacts

Britney-Ann Wray, BS, CTBS, CCRP

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2025

First Posted

March 14, 2025

Study Start

February 25, 2025

Primary Completion (Estimated)

February 25, 2075

Study Completion (Estimated)

February 25, 2075

Last Updated

March 14, 2025

Record last verified: 2025-03

Locations